{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:18:27Z","timestamp":1794057507541,"version":"4.8.0"},"reference-count":7,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,26]]},"DOI":"10.1515\/cclm-2023-1490","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T21:20:38Z","timestamp":1709673638000},"page":"e193-e196","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitis"],"prefix":"10.1515","volume":"62","author":[{"given":"Yazhen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory , Hangzhou 631689 Xixi Hospital , Hangzhou , Zhejiang , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory , Hangzhou 631689 Xixi Hospital , Hangzhou , Zhejiang , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory , Hangzhou 631689 Xixi Hospital , Hangzhou , Zhejiang , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaochan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory , Hangzhou 631689 Xixi Hospital , Hangzhou , Zhejiang , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aifang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory , Hangzhou 631689 Xixi Hospital , Hangzhou , Zhejiang , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"2024071605441141815_j_cclm-2023-1490_ref_001","doi-asserted-by":"crossref","unstructured":"Younossi, ZM, Bernstein, D, Shiffman, ML, Kwo, P, Kim, WR, Kowdley, KV, et al.. Diagnosis and management of primary biliary cholangitis. Am J\u00a0Gastroenterol 2019;114:48\u201363. https:\/\/doi.org\/10.1038\/s41395-018-0390-3.","DOI":"10.1038\/s41395-018-0390-3"},{"key":"2024071605441141815_j_cclm-2023-1490_ref_002","doi-asserted-by":"crossref","unstructured":"Tanaka, A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol 2021;27:1\u201321. https:\/\/doi.org\/10.3350\/cmh.2020.0028.","DOI":"10.3350\/cmh.2020.0028"},{"key":"2024071605441141815_j_cclm-2023-1490_ref_003","doi-asserted-by":"crossref","unstructured":"Hu, S, Zhao, F, Wang, Q, Chen, WX. The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis. Clin Chem Lab Med 2014;52:1533\u201342. https:\/\/doi.org\/10.1515\/cclm-2013-0926.","DOI":"10.1515\/cclm-2013-0926"},{"key":"2024071605441141815_j_cclm-2023-1490_ref_004","doi-asserted-by":"crossref","unstructured":"Muratori, P, Muratori, L, Ferrari, R, Cassani, F, Bianchi, G, Lenzi, M, et al.. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003;98:431\u20137. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07257.x.","DOI":"10.1111\/j.1572-0241.2003.07257.x"},{"key":"2024071605441141815_j_cclm-2023-1490_ref_005","doi-asserted-by":"crossref","unstructured":"de Liso, F, Matinato, C, Ronchi, M, Maiavacca, R. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature. Clin Chem Lab Med 2017;56:25\u201331. https:\/\/doi.org\/10.1515\/cclm-2017-0249.","DOI":"10.1515\/cclm-2017-0249"},{"key":"2024071605441141815_j_cclm-2023-1490_ref_006","doi-asserted-by":"crossref","unstructured":"Wang, M, Jin, Y, Xu, A. Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis. Clin Chem Lab Med 2024;62:e53\u20135. https:\/\/doi.org\/10.1515\/cclm-2023-0742.","DOI":"10.1515\/cclm-2023-0742"},{"key":"2024071605441141815_j_cclm-2023-1490_ref_007","doi-asserted-by":"crossref","unstructured":"Lindor, KD, Bowlus, CL, Boyer, J, Levy, C, Mayo, M. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology 2019;69:394\u2013419. https:\/\/doi.org\/10.1002\/hep.30145.","DOI":"10.1002\/hep.30145"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2023-1490\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2023-1490\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T05:47:33Z","timestamp":1721108853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2023-1490\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":7,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,2,19]]},"published-print":{"date-parts":[[2024,7,26]]}},"alternative-id":["10.1515\/cclm-2023-1490"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2023-1490","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}